While Merck is pre-occupied planning its appeal of last week's judgment against the company in the first Vioxx liability case, it is hoped that Merck's CEO and other pharmaceutical executives correctly interpret and learn from the jury's messages.

The industry should consider this jury as an independent focus group. Focus groups are often used by the industry to do market research. The difference is, this group was presented both sides of the case and had access to a lot of information, including the good, the bad, and the ugly.

Read today's post to Pharma Marketing Blog.